Tian Yuan has gathered elite lawyers in various fields, has more than 200 partners, more than 800 professionals, and provides customers with all-round, cross-regional, comprehensive and one-stop legal services with profound practice experience and project experience. and best business solutions.


With 30 years of experience in legal practice and continuous innovation in practice, Tian Yuan's business covers the main practice fields and emerging fields of Chinese lawyers, and maintains the level of China's top lawyers and cross-team comprehensive service capabilities in many fields. Transactions and projects and cases with great industry influence.

Insights & News

Tian Yuan lawyers keep up with the trend of the industry, focus on legal hot topics, and rely on unique perspectives and market insights to help clients understand the latest changes in the law, and use professional observation, analysis and insights to help clients make more informed business choices and decisions.

About Us

As a leading law firm with a long history and profound culture in China, Tian Yuan has always been based on legal services, constantly exploring and innovating, and has moved forward with the Chinese economy for 30 years. We have offices in 14 economically active cities in China and enjoys a high reputation in the industry.

Laixiang Li

Mr. Laixiang (Joseph) Li’s expertise centers on a number of areas, including capital markets, mergers and acquisitions (M&A), private equity investments, and general corporate matters. Mr. Li joined the firm’s Shenzhen Office as a partner in 2023. Prior to that, he practiced law over 10 years at other top law firms in China.


Mr. Li regularly acts as counsel assisting issuers and underwriters with domestic and international IPOs. In the meantime, he has represented numerous investment funds or start-ups completing hundreds of PE/VC deals, involving company structures such as VIE structures, sino-foreign joint venture structures and domestic structure. .


Mr. Li has designed various deal structures in cross-border investment transactions and provided to his clients a full range of legal services including compliance advice, legal due diligence, drafting documents and negotiating.


In terms of industry and sector experience, Mr. Li has long-term collaborations with clients in high-tech or emerging industries such as life sciences, advanced manufacturing, and TMT, providing consulting advices for well-known professors and enterprises on equity structure design, industry-university-research transformation, license in/out, equity incentives, compliance, foreign exchange, and other aspects, providing a streamline of comprehensive legal support to founders from Day One to M&A or IPO exits.


Mr. Li also provides advice on non-profit organization-related advisory services, including the establishment of overseas NGO representative offices, international schools, foundations, charitable donations, charitable trusts and daily compliance of NGOs.


Work Highlights

Capital Markets


  • Kelun Biotech (06990.HK)’s Hong Kong IPO
  • Keep Inc. (03650.HK)’s Hong Kong IPO
  • Tencent Music Entertainment Group (NYSE: TME)’s US IPO and bond issuance
  • DouYu (NYSE: DOYU)’s US IPO
  • Sunlands Technology Group (NYSE: STG)’s US IPO
  • Aurora Mobile (NASDAQ: JG)’s US IPO
  • Borqs Technologies (NASDAQ: BRQS)’s SPAC listing
  • Bona Film Group’s U.S. privatization
  • Lauder Dynamics (002765)’s issuance of shares to purchase assets



Mergers & Acquisitions


  • Jiaman Dress’s acquisition of Hush Puppies-related IP assets in certain territories
  • QQ Music and China Music Corporation’s US$7 billion merger of equals
  • Tencent Music Entertainment’s acquisition of 100% shares in Lazy Audio
  • Tencent Music Entertainment’s acquisition of Ultimate
  • Bona Group’s acquisition of dozens of local Chinese movie theatres
  • Uxin’s sale of salvage-value used cars business to Boche
  • Uxin’s sale of used-car auction business to
  • Merge between Baidu Music and Taihe Music
  •’s acquisition of
  •’s acquisition of Anjuke
  • Lianjia’s purchase of Mantanghong and multiple real-estate agency institutions
  • Plum’s trade sale
  • Vectoring Pharmatech’s trade sale



Private Equity Investments


  • Analytical BioSciences’s multiple rounds of overseas financing
  • Edge Medical’s multiple rounds of domestic financing
  • Bone’s Technology’s multiple rounds of overseas financing of over 10 million dollars
  • VibroniX’s multiple rounds of domestic and overseas financing
  • BayOmics’s series A financing
  • Easy-Logic’s series A financing
  • IDG Capital’s RMB 900 million Pre-IPO investment in Growatt
  • IDG Capital’s series B investment in Huihe Healthcare
  • IDG Capital’s series B investment in SocialMED
  • IDG Capital’s series C investment in Xiaoxiandun
  • IDG Capital’s series A investment in Supreium
  • IDG Capital’s series A investment in FlowUs
  • IDG Capital’s series A investment in Future Robotics
  • IDG Capital’s series A investment in EarlyDiagnostics
  • IDG Capital’s series A investment in Seer Group
  • IDG Capital’s series A investment in Nikegen
  • IDG Capital’s series A investment in Corestar
  • IDG Capital’s series A investment in Start Bioservices (Yunxinzhili)
  • IDG Capital’s series A investment in Taichu Biotechnology
  • IDG Capital’s series C investment in WakeData
  • Hidden Hill Capital’s investment in Didi Freight
  • CITIC Goldstone Fund’s investment in Zhenshiming
  • Huatai Innovation Investment (Huatai Securities’ direct investment platform)’s series B strategic investment in Authine (A Low-code Platform)
  • Huatai Innovation Investment’s series B strategic investment in Cluster
  • Xiamen Jianfa’s Pre-IPO investment in Aeolon Wind Energy


  • Renmin University of China, Master of Law (2012)
  • Xiangtan University, Bachelor of Literature (2010)